X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-02 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $18.24 | -537 | 262,996 | 0% | -$9,795 | ||||||
2023-01-26 | IMVT | Levine Mark S. | GC | S - Sale | $18.51 | -10,156 | 245,660 | -4% | -$187,988 | ||||||
2023-01-11 | IMVT | Salzmann Peter | CEO | S - Sale | $16.80 | -4,021 | 993,932 | 0% | -$67,553 | ||||||
2023-01-11 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $16.79 | -60,490 | 331,419 | -15% | -$1,015,596 | ||||||
2023-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $16.75 | -4,510 | 268,347 | -2% | -$75,525 | ||||||
2023-01-11 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $16.75 | -44,568 | 263,533 | -14% | -$746,317 | ||||||
2022-10-21 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $9.67 | -341 | 308,101 | 0% | -$3,297 | ||||||
2022-10-13 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $9.18 | -928 | 391,909 | 0% | -$8,519 | ||||||
2022-10-13 | IMVT | Salzmann Peter | CEO | S - Sale | $9.18 | -2,793 | 997,953 | 0% | -$25,640 | ||||||
2022-10-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $9.44 | -12,500 | 272,857 | -4% | -$118,000 | ||||||
2022-10-06 | IMVT | Roivant Sciences Ltd. | 10% | P - Purchase | $6.00 | +416,667 | 73,805,331 | +1% | +$2,500,002 | ||||||
2022-09-30 | IMVT | Pande Atul | Dir | P - Purchase | $5.60 | +15,000 | 102,985 | +17% | +$84,000 | ||||||
2022-09-28 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.67 | -535 | 392,837 | 0% | -$2,498 | ||||||
2022-09-28 | IMVT | Salzmann Peter | CEO | S - Sale | $4.67 | -1,605 | 1,000,746 | 0% | -$7,495 | ||||||
2022-09-29 | IMVT | Torti Frank | Dir | P - Purchase | $5.81 | +20,000 | 393,358 | +5% | +$116,200 | ||||||
2022-08-30 | IMVT | Salzmann Peter | CEO | S - Sale | $5.83 | -1,644 | 1,002,351 | 0% | -$9,585 | ||||||
2022-08-30 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $5.83 | -548 | 393,372 | 0% | -$3,195 | ||||||
2022-07-27 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.27 | -510 | 281,104 | 0% | -$2,178 | ||||||
2022-07-27 | IMVT | Salzmann Peter | CEO | S - Sale | $4.27 | -1,528 | 552,731 | 0% | -$6,525 | ||||||
2022-07-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $4.70 | -322 | 195,626 | 0% | -$1,513 | ||||||
2022-06-29 | IMVT | Salzmann Peter | CEO | S - Sale | $4.02 | -1,376 | 554,259 | 0% | -$5,532 | ||||||
2022-06-29 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.02 | -460 | 281,614 | 0% | -$1,849 | ||||||
2022-05-24 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $3.79 | -492 | 282,074 | 0% | -$1,865 | ||||||
2022-05-24 | IMVT | Salzmann Peter | CEO | S - Sale | $3.79 | -1,471 | 555,635 | 0% | -$5,575 | ||||||
2022-04-27 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $4.72 | -541 | 282,566 | 0% | -$2,554 | ||||||
2022-04-27 | IMVT | Salzmann Peter | CEO | S - Sale | $4.72 | -1,622 | 557,106 | 0% | -$7,656 | ||||||
2022-04-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $4.98 | -1,392 | 195,948 | -1% | -$6,932 | ||||||
2022-03-24 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $5.90 | -6,381 | 283,107 | -2% | -$37,648 | ||||||
2022-03-24 | IMVT | Salzmann Peter | CEO | S - Sale | $5.90 | -19,227 | 558,728 | -3% | -$113,439 | ||||||
2022-01-07 | IMVT | Butchko Julia G. | Chief Dev., Tech. Officer | S - Sale | $7.25 | -55,318 | 289,488 | -16% | -$401,056 | ||||||
2022-01-07 | IMVT | Barnett Eva Renee | CFO | S - Sale | $7.25 | -29,959 | 172,541 | -15% | -$217,203 | ||||||
2022-01-07 | IMVT | Salzmann Peter | CEO | S - Sale | $7.25 | -125,158 | 577,955 | -18% | -$907,396 | ||||||
2022-01-05 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $8.28 | -26,813 | 197,340 | -12% | -$222,012 | ||||||
2021-08-27 | IMVT | Hughes Douglas J. | Dir | P - Purchase | $8.24 | +18,247 | 58,447 | +45% | +$150,355 | ||||||
2021-08-20 | IMVT | Migausky George V | Dir | P - Purchase | $7.65 | +7,000 | 67,200 | +12% | +$53,550 | ||||||
2021-08-13 | IMVT | Pande Atul | Dir | P - Purchase | $7.98 | +5,000 | 45,200 | +12% | +$39,900 | ||||||
2021-08-10 | IMVT | Fromkin Andrew J. | Dir | P - Purchase | $7.90 | +5,500 | 45,700 | +14% | +$43,450 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |